Trials / Completed
CompletedNCT02195258
Pharmacogenetic of Salbutamol in Pediatric Asthma Crisis
Pharmacogenetic of the Salbutamol Efficacy in Asthma Crisis for Children in Emergency Department
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 95 (actual)
- Sponsor
- Hôpital Necker-Enfants Malades · Academic / Other
- Sex
- All
- Age
- 6 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
this study is designed to identify the genetic factors which can be implicated in the salbutamol responsiveness for asthmatic children in pediatric emergency department
Detailed description
Patients from 6 to 16 years old consulting for an acute asthma exacerbation and receiving a treatment by salbutamol according to the usual care could be recruited.Saliva from patient were collected using Oragen®.DNA OG-500 kit or swabs.Based on literature review, four SNP were chosen:ADBR2 gene), ARG gene, and GSNOR gene.
Conditions
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2012-05-01
- Completion
- 2013-06-01
- First posted
- 2014-07-21
- Last updated
- 2014-07-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02195258. Inclusion in this directory is not an endorsement.